Cargando…

Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status

BACKGROUND: Autophagy is a cellular pathway that regulates transportation of cytoplasmic macromolecules and organelles to lysosomes for degradation. Autophagy is involved in both tumorigenesis and tumour suppression. Here we investigated the potential prognostic value of the autophagy-related protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Klaus Juergen, Ademi, Ceflije, Bertram, Stefanie, Schmid, Kurt Werner, Baba, Hideo Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957418/
https://www.ncbi.nlm.nih.gov/pubmed/27444698
http://dx.doi.org/10.1186/s12957-016-0946-x
_version_ 1782444180325269504
author Schmitz, Klaus Juergen
Ademi, Ceflije
Bertram, Stefanie
Schmid, Kurt Werner
Baba, Hideo Andreas
author_facet Schmitz, Klaus Juergen
Ademi, Ceflije
Bertram, Stefanie
Schmid, Kurt Werner
Baba, Hideo Andreas
author_sort Schmitz, Klaus Juergen
collection PubMed
description BACKGROUND: Autophagy is a cellular pathway that regulates transportation of cytoplasmic macromolecules and organelles to lysosomes for degradation. Autophagy is involved in both tumorigenesis and tumour suppression. Here we investigated the potential prognostic value of the autophagy-related proteins Beclin-1, p62, LC3 and uncoordinated (UNC) 51-like kinase 1 (ULK1) in a cohort of colorectal cancer (CRC) specimens. METHODS: In this study, we analysed the immunoexpression of the autophagy-related proteins p62, LC3, Beclin-1 and ULK1 in 127 CRC patients with known KRAS mutational status and detailed clinical follow-up. RESULTS: Survival analysis of p62 staining showed a significant correlation of cytoplasmic (not nuclear) p62 expression with a favourable tumour-specific overall survival (OS). The prognostic power of cytoplasmic p62 was found in the KRAS-mutated subgroup but was lost in the KRAS wildtype subgroup. Survival analysis of Beclin-1 staining did not show an association with OS in the complete cohort. LC3 overexpression demonstrated a slight, though not significant, association with decreased OS. Upon stratifying cases by KRAS mutational status, nuclear (not cytoplasmic) Beclin-1 staining was associated with a significantly decreased OS in the KRAS-mutated subgroup but not in the KRAS wildtype CRCs. In addition, LC3 overexpression was significantly associated with decreased OS in the KRAS-mutated CRC subgroup. ULK1 expression was not correlated to survival. CONCLUSIONS: Immunohistochemical analyses of LC3, p62 and Beclin-1 may constitute promising novel prognostic markers in CRC, especially in KRAS-mutated CRCs. This strategy might help in identifying high-risk patients who would benefit from autophagy-related anticancer drugs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12957-016-0946-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4957418
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49574182016-07-23 Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status Schmitz, Klaus Juergen Ademi, Ceflije Bertram, Stefanie Schmid, Kurt Werner Baba, Hideo Andreas World J Surg Oncol Research BACKGROUND: Autophagy is a cellular pathway that regulates transportation of cytoplasmic macromolecules and organelles to lysosomes for degradation. Autophagy is involved in both tumorigenesis and tumour suppression. Here we investigated the potential prognostic value of the autophagy-related proteins Beclin-1, p62, LC3 and uncoordinated (UNC) 51-like kinase 1 (ULK1) in a cohort of colorectal cancer (CRC) specimens. METHODS: In this study, we analysed the immunoexpression of the autophagy-related proteins p62, LC3, Beclin-1 and ULK1 in 127 CRC patients with known KRAS mutational status and detailed clinical follow-up. RESULTS: Survival analysis of p62 staining showed a significant correlation of cytoplasmic (not nuclear) p62 expression with a favourable tumour-specific overall survival (OS). The prognostic power of cytoplasmic p62 was found in the KRAS-mutated subgroup but was lost in the KRAS wildtype subgroup. Survival analysis of Beclin-1 staining did not show an association with OS in the complete cohort. LC3 overexpression demonstrated a slight, though not significant, association with decreased OS. Upon stratifying cases by KRAS mutational status, nuclear (not cytoplasmic) Beclin-1 staining was associated with a significantly decreased OS in the KRAS-mutated subgroup but not in the KRAS wildtype CRCs. In addition, LC3 overexpression was significantly associated with decreased OS in the KRAS-mutated CRC subgroup. ULK1 expression was not correlated to survival. CONCLUSIONS: Immunohistochemical analyses of LC3, p62 and Beclin-1 may constitute promising novel prognostic markers in CRC, especially in KRAS-mutated CRCs. This strategy might help in identifying high-risk patients who would benefit from autophagy-related anticancer drugs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12957-016-0946-x) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-22 /pmc/articles/PMC4957418/ /pubmed/27444698 http://dx.doi.org/10.1186/s12957-016-0946-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Schmitz, Klaus Juergen
Ademi, Ceflije
Bertram, Stefanie
Schmid, Kurt Werner
Baba, Hideo Andreas
Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status
title Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status
title_full Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status
title_fullStr Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status
title_full_unstemmed Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status
title_short Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status
title_sort prognostic relevance of autophagy-related markers lc3, p62/sequestosome 1, beclin-1 and ulk1 in colorectal cancer patients with respect to kras mutational status
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957418/
https://www.ncbi.nlm.nih.gov/pubmed/27444698
http://dx.doi.org/10.1186/s12957-016-0946-x
work_keys_str_mv AT schmitzklausjuergen prognosticrelevanceofautophagyrelatedmarkerslc3p62sequestosome1beclin1andulk1incolorectalcancerpatientswithrespecttokrasmutationalstatus
AT ademiceflije prognosticrelevanceofautophagyrelatedmarkerslc3p62sequestosome1beclin1andulk1incolorectalcancerpatientswithrespecttokrasmutationalstatus
AT bertramstefanie prognosticrelevanceofautophagyrelatedmarkerslc3p62sequestosome1beclin1andulk1incolorectalcancerpatientswithrespecttokrasmutationalstatus
AT schmidkurtwerner prognosticrelevanceofautophagyrelatedmarkerslc3p62sequestosome1beclin1andulk1incolorectalcancerpatientswithrespecttokrasmutationalstatus
AT babahideoandreas prognosticrelevanceofautophagyrelatedmarkerslc3p62sequestosome1beclin1andulk1incolorectalcancerpatientswithrespecttokrasmutationalstatus